Osteoporosis: now and the future
Top Cited Papers
- 29 March 2011
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 377 (9773) , 1276-1287
- https://doi.org/10.1016/s0140-6736(10)62349-5
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (1875/12-1, 1875/13-1, HO 1875/8-1, Transregio-67 (B2)
This publication has 95 references indexed in Scilit:
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyJournal of Clinical Oncology, 2010
- Update in New Anabolic Therapies for OsteoporosisJournal of Clinical Endocrinology & Metabolism, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2009
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myelomaBlood, 2009
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in miceJournal of Clinical Investigation, 2009
- Giant Osteoclast Formation and Long-Term Oral Bisphosphonate TherapyNew England Journal of Medicine, 2009
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast CancerJournal of Clinical Oncology, 2008
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trialBone, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007